Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-021-00739-5, published online 03 December 2021
After online publication of the letter1, the author found two images in the supplement materials were used incorrectly. Additionally, there is an error in the chemical structure of Aiphanol in Figs. 1a and 1s that needs to be corrected. The correct data are provided as follows. The key findings of the article are not affected by these corrections. The original article has been corrected.
a Structure of Aiphanol. s The schematic representation of the mechanism
Transwell chamber analysis of SGR’s effects on the migratory and invasive abilities of HUVECs. Migrated or invaded cells were photographed and relative migration/invasion value was calculated (n = 6 per group). Scale bar, 100 μm. *P < 0.05; **P < 0.01; ***P < 0.001.
Matrigel plug assay of Aiphanol’s inhibition on the newly formed vessels. Paraffin-embedded sections of Matrigel plugs were stained with Hematoxylin and eosin (HE) or probed with anti-CD31 (brown). The numbers of neovessels (red arrows) were counted and compared (n = 4 per group). Scale bar, 0.5 cm (plugs) and 50 μm (sections). Data represented mean ± SEM. *P < 0.05.
Change history
16 May 2022
The original version has been corrected: Figures presented in this correction note reordered according to the sequence.
Reference
Chen, S. et al. Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2. Signal Transduct. Target Ther. 6, 413, https://doi.org/10.1038/s41392-021-00739-5 (2021).
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, S., Feng, J., Zhao, C. et al. Correction: Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2. Sig Transduct Target Ther 7, 144 (2022). https://doi.org/10.1038/s41392-022-00988-y
Published:
DOI: https://doi.org/10.1038/s41392-022-00988-y
